Characterization of histamine release induced by fluoroquinolone antibacterial agents in-vivo and in-vitro

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 5, 2000, Pages 577-584

  Mori, Kazuhiko ^a   Maru, Chikako ^a   Takasuna, Kiyoshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HISTAMINE; LEVOFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL HETEROGENEITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PERITONEUM MAST CELL; RAT; SKIN CELL; SPECIES DIFFERENCE;

EID: 0034077315     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774228     Document Type: Article

References (29)

1. Aoki, H., Okazaki, O., Kurata, T., Shintani, S., Tachizawa, H., Hakusui, H. (1991) The pharmacokinetics of DR-3355 (1): absorption, distribution and excretion after a single oral administration to rats. Xenobio. Metab. Dispos. 6: 793-803
2. Arcieri, G. M., Becker, N., Esposito, B., Griffith, E., Heyd, A., Neumann, C., O'Brien, B. (1989) Safety of intravenous ciprofloxacin. A review. Am. J. Med. 87(Suppl. 5A): 92S-97S
3. Barrett, K. E., Ali, H., Pearce, F. L. (1985) Studies on histamine secretion from enzymatically dispersed cutaneous mast cells of the rat. J. Invest. Dermatol. 84: 22-26
4. de Mora, F., Garcia, G., Ferrer, L., Arboix, M. (1993) Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet. Immunol. Immunopathol. 39: 421-429
5. Ennis, M., Amon, E. U., Lorenz, W. (1989) Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents Actions 27: 101-103
6. Furuhata, K., Hayakawa, H., Soumi, K., Arai, H., Watanabe, Y., Narita, H. (1998a) Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration. Biol. Pharm. Bull. 21: 456-460
7. Furuhata, K., Fukuda, Y., Soumi, K., Arai, H., Watanabe, Y., Narita, H. (1998b) Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. Dermovascular permeability-increasing effect and action on peritoneal mast cells. Biol. Pharm. Bull. 21: 461-464
8. Genovese, A., Stellato, C., Marsella, C. V., Adt, M., Marone, G. (1996) Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int. Arch. Allergy Immunol. 110: 13-22
9. Kojima, H., Hirohashi, M., Sakurai, T., Kasai, Y., Akashi, A. (1984) General pharmacology of DL-8280. Chemotherapy 32(Suppl. 1): 1148-1161
10. Kurata, M., Kasuga, Y., Nanbe, E., Nakamura, H., Asano, T., Haruta, K. (1995) Flush induced by fluoroquinolones in canine skin. Inflamm. Res. 44: 461-465
11. Lagunoff, D., Martin, T. W. (1983) Agents that release histamine from mast cells. Ann. Rev. Pharmacol. Toxicol. 23: 331-351
12. Lawman, M. A., Rees, P. H., Benyon, R. C., Church, M. K. (1988) Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimunologic stimuli. J. Allergy Clin. Immunol. 81: 590-597
13. Mon, K., Hagiwara, T., Takasuna, K., Nomura, M. (1996) Species differences in histamine release induced by fluoroquinolones. Jpn. J. Pharmacol. 71(Suppl.): 146
14. Muldoon, S. M., Donlon, M. A., Todd, R., Helgeson, E. A., Freas, W. (1984) Plasma histamine and hemodynamics responses following administration of nalbuphine and morphine. Agents Actions 15: 229-234
15. Nakagawa, T., Shimada, J., Mizushima, Y., Takaishi, T., Morita, Y. (1995) Effect of ciprofloxacin on histamine release from human and rat mast cells. Jpn. J. Inflamm. 15: 337-338
16. Nishiyama, R., Tasaka, K., Irino, S. (1957) The site of some histamine-releasing substances in the dog. Acta. Med. Okayama 11: 133-144
17. Pearce, F. L. (1982) Functional heterogeneity of mast cells from different species and tissues. Klin. Wochenschr. 60: 954-957
18. Pearce, F. L., Ennis, M. (1980) Isolation and some properties of mast cells from the mesentery of the rat and guinea pig. Agents Actions 10: 124-131
19. Schacht, P., Arcieri, G., Branolte, J., Bruck, H., Chyský, V., Griffith, E., Gruenwaldt, G., Hullmann, C., Konopka, C. A., O'Brien, B., Rahm, V., Ryoki, T., Westwood, A., Weuta, H. (1988) Worldwide clinical data on efficacy and safety of ciprofloxacin. Infection 16(Suppl.): S29-S43
20. Shanahan, F., Denburg, J. A., Fox, J., Bienenstock. J., Befus, D. (1985) Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J. Immunol. 135: 1331-1337
21. Shar, P. M., Mulert, R. (1990) Safety profile of quinolones. Eur. Urol. 17(Suppl. 1): 46-51
22. Smythe, M. A., Rybak, M. J. (1989) Ofloxacin: A review. Drug Intell. Clin. Pharm. Ann. Pharmacother. 23: 839-846
23. Stahlmann, R. (1990) Safety profile of the quinolones. J. Antimicrob. Chemother. 26(Suppl. D): 31-44
24. Takasuna, K., Kasai, K., Usui, C., Takahashi, M., Hirohashi, M., Tamura, K., Takayama, S. (1992) General pharmacology of the new quinolone antibacterial agent levofloxacin. Arzneim. Forsch. Drug. Res. 42: 408-418
25. Thorsteinsson, S. B., Bergan, T., Johannesson, G., Thorsteinsson, H. S., Rohwedderm, R. (1987) Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram. Chemotherapy 33: 448-451
26. Thorsteinsson, S. B., Bergan, T., Rohwedder, R. (1988) Tolerance of intravenously administered ciprofloxacin. Chemotherapy 34: 256-260
27. Une, T., Fujimoto, T., Sato, K., Osada, Y. (1988) In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob. Agents Chemother. 32: 1336-1340
28. Verho, M., Malerczyk, V., Grötsch, H., Lorenz, H. (1988) Absence of crystalluria and estimation of renal parameters after oral and intravenous ofloxacin as compared to placebo in healthy volunteers. Drug Exp. Clin. Res. 14: 539-545
29. Yoshida, M., Takayama, S., Kato, M. (1994) Effect of levofloxacin and ciprofloxacin injection on permeability of the tail vein in mice and skin microvasculature in rats. Int. J. Tissue React. 16: 105-112